specifically studied genetic risk components of moderate‐to‐severe asthma that were defined by the appropriate medication or the diagnosis by a doctor and identified three loci associated with moderate‐to‐severe asthma, including signals in KIAA1109, MUC5AC, and GATA3.12 This evidence concerns the gene BLTP1 and asthma.